Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers has found.

DEA Opens Cannabis Rescheduling Comment Period

The Drug Enforcement Administration published its proposed rescheduling of cannabis today. There is a comment period that ends on July 22nd. The biggest outcome of

May 21, 2024

WHO director-general calls out critics of planned pandemic accords – Pharmaceutical Technology

Member states began developing the pandemic accords in February 2022 and the agency has continued to hold meetings in 2023. Credit: Elenarts via Shutterstock. At

July 20, 2023

Innovative approach by Waymark enhances health outcomes for Medicaid patients

Waymark, a public benefit company dedicated to improving access and quality of care in Medicaid, today published a peer-reviewed study in the New England Journal

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.